160 related articles for article (PubMed ID: 25671290)
1. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915).
Takahashi H; Riether D; Bartolozzi A; Bosanac T; Berger V; Binetti R; Broadwater J; Chen Z; Crux R; De Lombaert S; Dave R; Dines JA; Fadra-Khan T; Flegg A; Garrigou M; Hao MH; Huber J; Hutzler JM; Kerr S; Kotey A; Liu W; Lo HY; Loke PL; Mahaney PE; Morwick TM; Napier S; Olague A; Pack E; Padyana AK; Thomson DS; Tye H; Wu L; Zindell RM; Abeywardane A; Simpson T
J Med Chem; 2015 Feb; 58(4):1669-90. PubMed ID: 25671290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and biological screening of N-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2yl-2"-sulfanyl acetamide.
Siddiqui SZ; Rehman A; Abbasi MA; Abbas N; Khan KM; Ashraf M; Ejaz SA
Pak J Pharm Sci; 2013 May; 26(3):455-63. PubMed ID: 23625417
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and biological screening of 5-substituted-1,3,4-oxadiazole-2yl-N-(2-methoxy-5-chlorophenyl)-2-sulfanyl acetamide.
Rehman A; Fatima A; Abbas N; Abbasi MA; Khan KM; Ashraf M; Ahmad I; Ejaz SA
Pak J Pharm Sci; 2013 Mar; 26(2):345-52. PubMed ID: 23455206
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
[TBL] [Abstract][Full Text] [Related]
5. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.
Bashir B; Shahid W; Ashraf M; Saleem M; Aziz-Ur-Rehman ; Muzaffar S; Imran M; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105243. PubMed ID: 34403937
[TBL] [Abstract][Full Text] [Related]
6. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor.
Stock N; Baccei C; Bain G; Broadhead A; Chapman C; Darlington J; King C; Lee C; Li Y; Lorrain DS; Prodanovich P; Rong H; Santini A; Zunic J; Evans JF; Hutchinson JH; Prasit P
Bioorg Med Chem Lett; 2010 Jan; 20(1):213-7. PubMed ID: 19914828
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new sulfonamides as lipoxygenase inhibitors.
Mustafa G; Khan IU; Ashraf M; Afzal I; Shahzad SA; Shafiq M
Bioorg Med Chem; 2012 Apr; 20(8):2535-9. PubMed ID: 22436389
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
10. Discovery of N-(1-(3-(4-phenoxyphenyl)-1,2,4-oxadiazol-5-yl)ethyl)acetamides as novel acetyl-CoA carboxylase 2 (ACC2) inhibitors with peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistic activity.
Okazaki S; Noguchi-Yachide T; Sakai T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
Bioorg Med Chem; 2016 Nov; 24(21):5258-5269. PubMed ID: 27591006
[TBL] [Abstract][Full Text] [Related]
11. Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
Filosa R; Peduto A; Aparoy P; Schaible AM; Luderer S; Krauth V; Petronzi C; Massa A; de Rosa M; Reddanna P; Werz O
Eur J Med Chem; 2013 Sep; 67():269-79. PubMed ID: 23871907
[TBL] [Abstract][Full Text] [Related]
12. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
[TBL] [Abstract][Full Text] [Related]
13. Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitor.
Maciolek CM; Ma B; Menzel K; Laliberte S; Bateman K; Krolikowski P; Gibson CR
Drug Metab Dispos; 2011 May; 39(5):763-70. PubMed ID: 21325431
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and local anesthetic activity of some novel N-[5-(4-substituted)phenyl-1,3,4-oxadiazol-2-yl]-2-(substituted)-acetamides.
Rajak H; Kharya MD; Mishra P
Arch Pharm (Weinheim); 2008 Apr; 341(4):247-61. PubMed ID: 18293435
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
[TBL] [Abstract][Full Text] [Related]
17. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-{(5-phenyl-1,3,4-Oxadiazol-2-yl)sulfanyl}-N-substituted acetamides as potential antimicrobial and hemolytic agents.
Rehman AU; Abbasi MA; Siddiqui SZ; Ahmad I; Shahid M; Subhani Z
Pak J Pharm Sci; 2016 May; 29(3):801-9. PubMed ID: 27166551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
